Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cullin-3 is a core scaffold protein of Cullin-RING E3 ubiquitin ligase complexes, fundamental to the ubiquitin–proteasome system that mediates the selective ubiquitination and proteasomal degradation of many proteins within the cell. CUL3 regulates a wide array of essential cellular processes—cell cycle progression, stress responses, protein trafficking, transcription, blood pressure regulation, and development—by recruiting various substrate-recognition proteins and linking them to the E2 ubiquitin-conjugating enzyme via the RING protein RBX1. Dynamic activation via neddylation (covalent attachment of the ubiquitin-like modifier NEDD8) is required for its ligase function. Genetic disruption of CUL3 leads to broad pathological effects, including neurodevelopmental disorders, hypertension, and cancer. CUL3 is studied as a potential therapeutic target and a biomarker, though direct pharmacologic inhibitors remain mostly investigational.
Inhibition of CUL3 neddylation → inhibition of E3 ubiquitin ligase activity (e.g., by NEDD8 pathway inhibitors). Modulation of protein homeostasis via altered substrate ubiquitination and degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cullin-3 (CUL3).